[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 7, Number 5 (Sep & Oct 2017) ::
J Research Health 2017, 7(5): 979-980 Back to browse issues page
Cervical cancer vaccine as a priority of public health practices in Iran
Samira Shahbazzadegan, Malihe Pishvaei
Social Development & Health Promotion Research Center, Gonabad University of Medical Sciences, Gonabad,Iran
Abstract:   (105 Views)
Cervical cancer is the third most common cancer in women. In poor countries, it is the second cause of cancer death [1]. According to official report of World Health Organization, about 500,000 new cases of cervical cancer were recorded each year that more than half of them are leading to death. 80 percent of new cases are occurred in developing countries [2].
Keywords: Cervical cancer, vaccine, priority, public, health, practices
Full-Text [PDF 240 kb]   (93 Downloads)    
Type of Study: Letter to Editor | Subject: Applicable
Received: 2017/07/8 | Accepted: 2017/08/28 | Published: 2017/08/28
Send email to the article author

Add your comments about this article
Your username or email:

Write the security code in the box >



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shahbazzadegan S, Pishvaei M. Cervical cancer vaccine as a priority of public health practices in Iran. J Research Health. 2017; 7 (5) :979-980
URL: http://jrh.gmu.ac.ir/article-1-1433-en.html
Volume 7, Number 5 (Sep & Oct 2017) Back to browse issues page
Journal of Research and Health
Persian site map - English site map - Created in 0.047 seconds with 786 queries by yektaweb 3463